InsidersTradesSigma
Bonesupport Holding AB: insider trades · Finland · FIN-FSA
FI:bonesupport-holding-abSE0009858152FI·FIN-FSAMcap 16.0Bn€Healthcare & Pharma
Discover the full directors' dealings record of Bonesupport Holding AB, a listed issuer based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare & Pharma sector, Bonesupport Holding AB has logged 13 insider filings. Market capitalisation: €16bn. The latest transaction was disclosed on 13 May 2026 — Purchase. Among the most active insiders: Lennart Johansson. Every trade is openly available.
13
Insider Decl.
0
Thresholds
€5m
12 ops.
Buy Volume
€139,370
1 ops.
Sell Volume
Financial data
242.80 €
Analyst consensus
6 analysts320.00 €Target 377.17 €(+55%)428.00 €
Income statement
Revenue1.17 Bn€
Gross profit1.09 Bn€93% margin
Net income142.2 M€15.2% margin
Valuation
PER (trailing)87.7x
PER (forward)31.7x
P/Book17.0x
Beta0.48
Balance sheet & cash
Market cap15.99 Bn€
Total debt11.7 M€
Free Cash Flow216.1 M€
Debt / Equity2%
Profitability & ownership
ROE22.0%
ROA19.9%
% insiders13.3%
% institutions60.8%
Last declaration on 13 May 2026
Declarations13 total
Executives●Purchase11FIN-FSA
SEK 31,6971,500 shares@ SEK 21.1311100.0% of flow
Aktie
FI:A003Y533-1·
Ideal exit: 6 Feb 2027 (T+270)
Executives●Purchase18FIN-FSA
€11,479534 shares@ €21.49590.0001% mcap52.6% of flow
Aktie
FI:A003Y521-1·
Ideal exit: 6 Feb 2027 (T+270)
Executives●Purchase17FIN-FSA
€29,4301,610 shares@ €18.27960.0002% mcap37.9% of flow
Aktie
FI:A003W902-1·
Ideal exit: 4 Dec 2026 (T+270)
Executives●Purchase21FIN-FSA
€90,0405,000 shares@ €18.00810.0006% mcap100.0% of flow
Aktie
FI:A003W558-1·
Ideal exit: 23 Nov 2026 (T+270)
Executives●Purchase17FIN-FSA
€27,5541,550 shares@ €17.77670.0002% mcap35.5% of flow
Aktie
FI:A003W415-1·
Ideal exit: 21 Nov 2026 (T+270)
Executives●Purchase16FIN-FSA
€20,7061,200 shares@ €17.25510.0001% mcap26.7% of flow
Aktie
FI:A003U189-1·
Ideal exit: 22 Aug 2026 (T+270)
Executives●Purchase19FIN-FSA
€90,4505,000 shares@ €18.090.0006% mcap57.3% of flow
Aktie
FI:A003T408-1·
Ideal exit: 4 Aug 2026 (T+270)
Executives●Purchase25FIN-FSA
€5m243,711 shares@ €19.00260.029% mcap100.0% of flow
Aktie
FI:A003T385-2·
Ideal exit: 2 Aug 2026 (T+270)
Executives●Sale33FIN-FSA
€139,3705,000 shares@ €27.87390.0009% mcap85.7% of flow
Aktie
FI:A003R383-2·
Executives●Purchase15FIN-FSA
€35,7151,205 shares@ €29.63880.0002% mcap22.6% of flow
Aktie
FI:A003R105-1·
Ideal exit: 24 Apr 2026 (T+270)
Executives●Purchase36FIN-FSA
€41,9881,798 shares@ €23.35260.0003% mcap100.0% of flow
Aktie
FI:A003P372-1·
Ideal exit: 1 Mar 2026 (T+270)
Executives●Purchase18FIN-FSA
€10,339443 shares@ €23.33920.0001% mcap47.4% of flow
Aktie
FI:A003P053-1·
Ideal exit: 22 Feb 2026 (T+270)
Executives●Purchase29FIN-FSA
€23,178771 shares@ €30.06230.0001% mcap14.3% of flow
Aktie
FI:A003M261-1·
Ideal exit: 2 Dec 2025 (T+270)
13 of 13 declarations
